
ObvioHealth Q&A: connecting DCT dots with remote tech
The move towards decentralised clinical trials has been accelerated by Covid-19, and the tech that underpins remote trials is evolving…
ByThe move towards decentralised clinical trials has been accelerated by Covid-19, and the tech that underpins remote trials is evolving…
ByDuring the Aβ targeting therapies symposium at this month's International Virtual Conference on Alzheimer’s disease and Parkinson’s disease (AD/PD 2021),…
ByJ&J’s single-shot Covid-19 vaccine has received emergency authorisation in both the US and EU. What has been the vaccine candidate’s…
ByThe Covid-19 pandemic has transformed clinical development. Rather than taking ten years to bring a drug to market, vaccine manufacturers…
ByDespite the theoretical potential of inactivated virus vaccines to offer a lead over other Covid-19 vaccine technologies against variants of…
ByLong-term Covid-19 vaccine durability has become less of an endgame since it has become increasingly likely additional shots will be…
BySince early March 2020, more than 500 companies have publicly announced disruptions to their planned and ongoing clinical trials due…
ByWith Johnson & Johnson (J&J) and Novavax, two more companies presented Covid-19 vaccine efficacy data last week. With an efficacy…
ByThank you for subscribing to Clinical Trials Arena